This Week in Virology15 Heinä 2023

TWiV 1025: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses the new risk assessment for the H5N1 avian flu viruses, the development of monoclonal antibody-based blocking ELISA for detecting SARS-CoV-2 exposure in animals, repeated antibiotic exposure and risk of hospitalization and death following COVID-19 infection, COVID-19 rebound study: a prospective cohort study to evaluate viral and symptom rebound differences in participants treated with Nirmatrelvir plus Ritonavir versus untreated controls, exaggerated blood pressure elevation in response to orthostatic challenge a post-acute sequelae of SARS-CoV-2 infection (PASC) after hospitalization, long term follow-up of a multicenter cohort of COVID-19 patients with pulmonary embolism, and risk of cardiovascular disease after COVID‐19 diagnosis among adults with and without diabetes.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

New risk assessment for H5N1 avian flu viruses (CDC)
Development of monoclonal antibody-based blocking ELISA for detecting SARS-CoV-2 exposure (Virology)
Repeated antibiotic exposure and risk of hospitalization and death following COVID-19 infection (eClinicalMedicine)
COVID-19 Rebound Study (CID)
Exaggerated blood pressure elevation in response to orthostatic challenge (AN)
Long term follow-up of a multicenter cohort of COVID-19 patients with pulmonary embolism (TR)
Risk of Cardiovascular disease after COVID‐19 diagnosis among adults with and without Diabetes (JAHA)
Contribute to our FIMRC fundraiser at PWB
Letters read on TWiV 1025
Dr. Griffin's COVID treatment summary (pdf)
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(1371)

TWiV Special: Albert Sabin with Karen Torghele

Vincent speaks with Karen Torghele about her recently published biography of polio vaccine pioneer Albert Sabin, the first ever written. Host: Vincent Racaniello Guest: Karen Torghele Subscribe (free)...

29 Kesä 1h 10min

TWiV 1335: TldR, bacterial hot rods and nullifying norovirus

TWiV explains research showing how temperate phages enhance bacterial host fitness via RNA-guided flagellar remodelling, and that IgA antibody is necessary and sufficient to prevent norovirus infectio...

28 Kesä 1h 55min

TWiV 1334: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello discuss the global economic burden of infectious disease, restoring trust in vaccinology, the Legionnaires outbreak in Harlem, new ...

27 Kesä 31min

TWiV 1334: Clinical update with Dr. Daniel Griffin

27 Kesä 31min

TWiV 1333: STING like a nanoparticle, float like HIV

TWiV explains research showing how HIV-1 signalling remodels nuclear pores to licence infection, and development of STING agonist nanoparticles to enable coordinated mucosal-systemic immunity for dura...

21 Kesä 1h 54min

TWiV Special: Ebola virus and Andes virus with John Dye

Vincent travels to ASM Microbe in Washington DC to speak with John Dye of the United States Army Medical Research Institute of Infectious Diseases about the recent outbreaks of Bundibugyo ebolavirus i...

20 Kesä 57min

TWiV 1332: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello express concern about vaccine policy and ACIP, scaling back of the CDC's role in global public health, shingles vaccine and dement...

20 Kesä 54min

TWiV 1331: A drug for cervical cancer

TWiV explains research showing that dairy cows are infected with low doses of influenza A(H5N1) and do not transmit efficiently to other animals, and covalent inhibitors of human papillomavirus type 1...

14 Kesä 1h 58min